Skip to search formSkip to main contentSkip to account menu

Episkin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Skin Irritancy Tests

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Successful proof of concept of a micronucleus genotoxicity assay on reconstructed epidermis exhibiting intrinsic metabolic activity.
2017
2017
Comparative assessment of local tolerance of alcohols commonly used in alcohol-based hand rubs for hand hygiene.
2014
2014
A new alternative method for testing skin irritation using a human skin model: a pilot study.
2010
2010
Use of in vitro testing to identify an unexpected skin sensitizing impurity in a commercial product: a case study.
2008
2008
Improvement of the Experimental Setup for Skin Absorption Screening Studies with Reconstructed Skin EPISKIN®
Percutaneous penetration studies are usually performed in human skin samples set up in a Franz® cell device. The ability to… 
2008
2008
Genotoxicity assays with Episkin ® , a reconstructed skin model: Towards new tools for in vitro risk assessment of dermally applied compounds?
In vitro reconstructed human skin such as Episkin® is a widely used model in safety or efficacy pre-screening tests. It is of… 
Review
2004
Review
2004
The validation of in vitro methods for skin irritation.
2002
2002
Reconstructed Skin Kits: Reproducibility of Cutaneous Irritancy Testing
The aim of this study was to determine the reproducibility of data obtained from in vitro irritation testing using three… 
1998
1998
An interlaboratory study of the reproducibility and relevance of Episkin, a reconstructed human epidermis, in the assessment of cosmetics irritancy.
1994
1994
Episkin: An in vitro model for the evaluation of phototoxicity and sunscreen photoprotective properties.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)